Private company
Baselake Partners, LP
Hedge fund that raised $6.9 million in 2022 (SEC Form D). Summary from the record
Last updated Oct 21, 2026.
Overview
Corporate structure
Baselake Partners, LP sits at the top of its group. 9 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Baselake Partners, LP DE
- Generation Bio Co. Stake · Cambridge, Massachusetts
- Kezar Life Sciences, Inc. Stake · South San Francisco, California, United States
- KIORA PHARMACEUTICALS INC Stake · Waltham, Massachusetts, United States
- LeonaBio, Inc. Stake · Bothell, Washington
- Neuphoria Therapeutics Inc. Stake · Burlington, Massachusetts
- Passage BIO, Inc. Stake · Philadelphia, Pennsylvania
- SYNLOGIC, INC. Stake · Winchester, Massachusetts
- TherapeuticsMD, Inc. Stake · Boca Raton, Florida, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Managing Member of the General Partner of the IssuerDavid Paolella named Jun 12, 20262
Filings
5 filings to the SEC since October 2021: 5 private raises. The latest 5:
- Jun 12, 2026D/A EDGAR
- Jun 12, 2025D/A EDGAR
- Jun 12, 2024D/A EDGAR
- Dec 14, 2023D/A EDGAR
- Dec 14, 2022D EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Baselake Partners, LP has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).
- KIORA PHARMACEUTICALS INCSCHEDULE 13G Sep 17, 20263
- TherapeuticsMD, Inc.SCHEDULE 13G/A Apr 6, 2026 to Aug 5, 20264
- Passage BIO, Inc.SCHEDULE 13G Jun 25, 20265
- Kezar Life Sciences, Inc.SCHEDULE 13G/A Apr 6, 2026 to May 28, 20266
- Generation Bio Co.SCHEDULE 13G/A Feb 6, 2026 to Feb 11, 20267
- LeonaBio, Inc.SCHEDULE 13G/A Nov 14, 2025 to Feb 6, 20268
- Neuphoria Therapeutics Inc.SCHEDULE 13G/A Oct 31, 2025 to Feb 6, 20269
- SYNLOGIC, INC.SCHEDULE 13G Jan 23, 202610
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $6.9M
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2022 | $6.9M | $6.9M |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10